Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Allergic Reactions

Allergic Reactions

Antibody Structure

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Allergic Drug Reactions

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...

Insulin Secretory Vesicles

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Basophils drive the resolution and promote wound healing in adult and aged mice.

The Journal of experimental medicine·2026

Same author

Complex mast cell CCL2-chemokine trafficking patterns during local allergic responses.

The Journal of allergy and clinical immunology·2026

Same author

LRO biogenesis and function: what can we learn from mast cells?

Frontiers in cell and developmental biology·2025

Same author

An Autocrine Regulator Loop Involving Tumor Necrosis Factor and Chemokine (C-C motif) Ligand-2 Is Activated by Transforming Growth Factor-β in Rat Basophilic Leukemia-2H3 Mast Cells.

International journal of molecular sciences·2025

Same author

IgE-Mediated Activation of Mast Cells and Basophils in Health and Disease.

Immunological reviews·2025

Same author

Divergent effects of tumor necrosis factor (TNF) in sepsis: a meta-analysis of experimental studies.

Critical care (London, England)·2024

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Detection of True IgE-expressing Mouse B Lineage Cells

Detection of True IgE-expressing Mouse B Lineage Cells

Published on: December 1, 2014

Stimulus-secretion coupling by high-affinity IgE receptor: new developments.

Marc Benhamou¹, Ulrich Blank

¹Inserm U699, Paris F-75018, France.

|September 21, 2010

Summary

Mast cells release mediators via IgE receptor (FcεRI) signaling. Recent discoveries reveal new effector molecules crucial for linking FcεRI activation to the regulated secretion process.

More Related Videos

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Published on: November 1, 2014

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Related Experiment Videos

Last Updated: Jun 8, 2026

Detection of True IgE-expressing Mouse B Lineage Cells

Detection of True IgE-expressing Mouse B Lineage Cells

Published on: December 1, 2014

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Published on: November 1, 2014

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Area of Science:

Immunology
Cell Biology
Molecular Biology

Background:

Mast cells, crucial immune cells, release mediators through high-affinity IgE receptor (FcεRI) signaling.
This release process involves vesicular transport and is tightly regulated to manage potentially harmful substances.
Effective signal transduction from FcεRI aggregation to the secretory machinery is vital for mast cell function.

Purpose of the Study:

To elucidate the molecular mechanisms underlying stimulus-secretion coupling in mast cells.
To highlight recent discoveries of novel effector molecules involved in FcεRI-mediated secretion.
To provide a clearer understanding of how FcεRI aggregation initiates the secretory cascade.

Main Methods:

Review of recent scientific literature and studies.
Analysis of molecular pathways involved in FcεRI signaling.
Identification and characterization of effector molecules linking receptor activation to secretion.

Main Results:

Identification of new effector molecules that bridge FcεRI signaling and the mast cell secretory apparatus.
Elucidation of the regulatory pathways governing the release of pre- and neoformed mediators.
A more comprehensive model of stimulus-secretion coupling in mast cells has emerged.

Conclusions:

Recent advancements have significantly improved our understanding of mast cell mediator secretion.
Novel effector molecules play a critical role in the regulated release of soluble mediators.
Further research into these pathways will enhance our knowledge of allergic responses and inflammation.